Mar 3, 2026 08:54AM
Feb 27, 2026 05:26PM
Feb 26, 2026 09:00AM
Feb 23, 2026 09:02AM
Feb 23, 2026 09:00AM
Feb 3, 2026 09:16AM
Feb 3, 2026 09:15AM Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
Jan 14, 2026 09:02AM
Jan 14, 2026 09:00AM
Jan 13, 2026 09:07AM
Jan 13, 2026 09:00AM
Dec 18, 2025 09:15AM
Dec 18, 2025 09:15AM
Nov 25, 2025 09:15AM PharmaCyte Biotech sells Femasys stake, boosts cash to $20 million
Nov 25, 2025 09:15AM
Nov 14, 2025 04:01PM
Nov 10, 2025 09:00AM
Nov 3, 2025 08:30AM
Nov 3, 2025 08:30AM
Oct 22, 2025 09:00AM
Oct 22, 2025 09:00AM Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
Oct 16, 2025 09:00AM
Oct 16, 2025 09:00AM
Sep 25, 2025 09:00AM
Sep 22, 2025 09:01AM
Sep 22, 2025 09:00AM
Sep 11, 2025 09:00AM
Sep 8, 2025 09:00AM Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
Sep 2, 2025 09:01AM
Sep 2, 2025 09:00AM
Aug 25, 2025 11:44PM
Aug 25, 2025 11:44PM
Aug 21, 2025 09:00AM
Aug 20, 2025 09:01AM
Aug 20, 2025 09:00AM Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control
Aug 8, 2025 04:05PM
Aug 6, 2025 09:00AM
Aug 6, 2025 09:00AM
Jul 1, 2025 09:00AM
Jun 26, 2025 06:44AM
Jun 25, 2025 09:00AM
Jun 25, 2025 09:00AM Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
Jun 17, 2025 09:01AM
Jun 17, 2025 09:00AM
Jun 11, 2025 09:00AM
May 8, 2025 05:01PM
Mar 27, 2025 09:00AM
Mar 19, 2025 09:20AM
Mar 18, 2025 09:00AM Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain
Mar 14, 2025 06:53AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All